Altria Q1 2025 Results: Net Profit Halves to $1.077 Billion; NJOY Suspension Triggers $873M Impairment

Apr.30.2025
Altria Q1 2025 Results: Net Profit Halves to $1.077 Billion; NJOY Suspension Triggers $873M Impairment
Altria Reports Q1 Results: Net Revenue Falls to $5.259 Billion, Down 5.7% Year-over-Year; Net Income Plunges 49.4% to $1.077 Billion.

【2Firsts】On April 29, 2025, Altria Group, an American tobacco company, announced its financial performance for the first quarter of 2025. The net revenue for the first quarter was $5.259 billion, a decrease of 5.7% compared to the same period last year; the net profit was $1.077 billion, a significant decrease of 49.4% compared to the previous year.

 

Altria Q1 2025 Results: Net Profit Halves to $1.077 Billion; NJOY Suspension Triggers $873M Impairment
Report | Image source: Altria

 

Key financial data

 

·Revenue Decline: Net revenue for the first quarter was $5.259 billion, a 5.7% decrease year-over-year. Net revenue after excluding consumption tax was $4.519 billion, a 4.2% decline year-over-year. The decline in revenue was primarily driven by lower shipment volumes in the combustible tobacco products division.

 

·Net profit decrease: During the reporting period, the company's net profit was $1.077 billion, a significant decrease of 49.4% compared to the same period last year. The main reason for the decrease in net profit is the decrease in operating company income (OCI), which includes non-cash impairment expenses of $873 million for the e-cigarette (e-vapor) reporting unit's goodwill, as well as costs related to the acquisition of NJOY.

 

Department Performance Analysis

 

Oral Tobacco Products:

· Net revenue was $654 million, an increase of 0.5% compared to the previous year. Net revenue growth remained at 0.5% after deducting consumption tax. 

·Adjusted operating cash income was flat compared to last year at $435 million. The positive impact of pricing increases was offset by a decrease in shipment volume, changes in product mix (higher proportion of on! nicotine pouches), and increased promotional spending. 

·Total shipment volume decreased by 5.0% to 175.4 million cans. The modern nicotine pouch brand on! performed well, with a 18.0% year-on-year increase in shipment volume to 39.3 million cans. on! increased its market share in the overall oral tobacco market in the US to 8.8% (up 1.8 percentage points year-on-year), and in the nicotine pouch segment to 17.9% (up 0.5 percentage points year-on-year). 

 

New tobacco products and others (AllOther - primarily including NJOY e-cigarettes): 

·NJOY (e-cigarette): NJOY consumables (pods, etc.) reported a 23.9% year-on-year increase in shipment volume to 13.5 million units. However, shipment volume of NJOY devices decreased significantly by 70% year-on-year to 300,000 units. NJOY consumables increased their retail market share in multiple channels and convenience stores in the US by 2.4 percentage points, reaching 6.6%. 

·ITC Ruling and Discontinuation: The US International Trade Commission's import ban and cease-and-desist order on NJOY ACE products will take effect on March 31, 2025. Retailers can still sell existing inventory, but NJOY has stopped shipping ACE products to wholesalers. As a result of this, Altria made a $873 million non-cash impairment charge to its e-cigarette reporting unit in the first quarter. 

 

Smokeable Products: 

·Net revenue was $4.622 billion, a decrease of 5.8% compared to the previous year. Net revenue decreased by 4.1% after deducting consumption tax. 

·Adjusted OCI increased by 2.7% to $2.518 billion, primarily due to higher pricing and cost control, partially offset by a decrease in shipment volume. 

·Domestic cigarette shipment volume reported a 13.7% decrease to 142.04 billion sticks, attributed to overall industry decline (due to growth of illegal e-cigarette products and consumer disposable income pressures), retail market share losses, and calendar differences. The retail share of Marlboro decreased by 1.0 percentage point to 41.0%.

 

Altria reiterated that its adjusted diluted earnings per share for the full year of 2025 will be between $5.30 and $5.45, representing a 2% to 5% increase from the 2024 baseline of $5.19. This guidance excludes the recent expenses related to the amortization of intangible assets, which have been considered as special projects. The company stated that this guidance takes into account the current economic environment, tariff impacts, enforcement of the illegal e-cigarette market, and assumes that ACE products will not return to the market within the year.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Product | Philip Morris Japan Teams Up With Renowned French Audio Brand DEVIALET for Limited-Edition IQOS Priced 60% Above Standard Model
Product | Philip Morris Japan Teams Up With Renowned French Audio Brand DEVIALET for Limited-Edition IQOS Priced 60% Above Standard Model
Philip Morris Japan (PMJ) launched the limited-edition IQOS ILUMA i PRIME Soundsorial Model in collaboration with French audio brand DEVIALET on October 1, 2026. Featuring sound-wave patterns, a silver-and-black finish and a gradient holder, the heated tobacco device is priced at JPY 15,980, including tax, and is available at four IQOS stores in Japan. According to Japanese media citing a PMJ representative, about 1,900 units were allocated to the Japanese retail market. A separate Soundsorial Collection, combining the device with DEVIALET Gemini II earbuds, includes 440 sets allocated to Japan for a membership prize draw.
product
Oct.23
STIIIZY Redesign Fails to Escape PAX Labs Patent Import Ban as Section 337 Case Also Involves China ALD
STIIIZY Redesign Fails to Escape PAX Labs Patent Import Ban as Section 337 Case Also Involves China ALD
U.S. Customs and Border Protection ruled that STIIIZY had not shown that the redesigned cannabis-vape products covered by its latest request fall outside an ITC limited exclusion order tied to PAX Labs patents. CBP accepted some of STIIIZY’s claim-construction and non-infringement arguments, but the company did not address two additional claims in the same patent. Earlier STIIIZY redesigned cartridges and certain associated components imported with them had received separate CBP clearance.
Sep.16
Special Report|Virginia Vape Directory Shows Contrast Between Vuse and JUUL Pod Systems and CrossBar 20K, Loon Flavored Disposables
Special Report|Virginia Vape Directory Shows Contrast Between Vuse and JUUL Pod Systems and CrossBar 20K, Loon Flavored Disposables
A 2Firsts analysis of Virginia's liquid nicotine and vapor product certification directory identified 213 product records from 15 manufacturers. Companies associated with BAT, Altria, Imperial Brands, JTI and JUUL account for 127 entries. The directory also includes independent brands CrossBar 20K, Loon and Breeze. CrossBar advertises a 13mL disposable capable of up to 20,000 puffs, while Loon has 16 disposable entries featuring fruit, cooling and beverage-related flavors. Of all records, 120 are labeled as under FDA PMTA review. Virginia introduced revised penalties on October 1, 2026, including a minimum first-violation civil penalty of $5,000 per unlisted product, alongside new retail tobacco permitting requirements.
Regulations
Oct.30
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
American Vapor Manufacturers (AVM) and Altria subsidiaries Helix Innovations and NJOY filed separate motions on October 7, 2026, seeking to intervene on the FDA's side in a lawsuit challenging its enforcement guidance for certain e-cigarette and nicotine pouch products with pending premarket tobacco product applications (PMTAs). Seven public health and tobacco-control organizations, including the Campaign for Tobacco-Free Kids, sued the agency in July to overturn the policy. AVM argues that vacating the guidance could disrupt orders, inventory, retail distribution and investments in regulatory submissions.
Regulations
Oct.09
Inside Nicotine-Pouch M&A Through Imperial's Yoik Deal: Latham, KPMG, PwC, Goldman Sachs and Morgan Stanley Form the Adviser Lineup
Inside Nicotine-Pouch M&A Through Imperial's Yoik Deal: Latham, KPMG, PwC, Goldman Sachs and Morgan Stanley Form the Adviser Lineup
Imperial Brands' acquisition of Swedish Helwit owner Yoik Group AB has highlighted the professional-services firms supporting cross-border oral nicotine M&A. Latham & Watkins and KPMG advised Imperial, while PwC and TM & Partners advised Yoik. KPMG also appeared on Imperial's acquisition of Black Buffalo earlier in 2026, while PwC played an extensive role in KT&G's acquisition of Swedish nicotine-pouch company Another Snus Factory. Imperial's public disclosures put the global modern oral nicotine delivery market at approximately £8.8 billion in retail sales and 23.5 billion pouches in 2024
Sep.20
Ispire Q4 Revenue Rebounds 33% but Full-Year Sales Still Fall 25% as FY2027 Focus Shifts to Malaysia Manufacturing, ODM, Nicotine Pouches and Age Verification
Ispire Q4 Revenue Rebounds 33% but Full-Year Sales Still Fall 25% as FY2027 Focus Shifts to Malaysia Manufacturing, ODM, Nicotine Pouches and Age Verification
Ispire Technology reported FY2026 revenue of about $96 million, down 24.7% year over year, as U.S. cannabis-vapor hardware and European e-cigarette sales declined by $17.4 million and $12.7 million, respectively. Fourth-quarter revenue rose 32.5% to $26.7 million, while quarterly gross margin fell to 6.3%. For FY2027, the company is prioritizing Malaysia manufacturing and vapor ODM while continuing to develop nicotine pouches, IKE Tech age-verification technology and G-Mesh licensing. Ispire has not separately disclosed the revenue or profit contribution of those newer businesses.
Regulations
Sep.17 by 2Firsts Perspectives